Pharma BD Deal Intelligence

Hospira, Inc. / Orchid Chemicals & Pharmaceuticals (Generic Injectables Business)

2010 · Asset Purchase · $400M · Complete

Announcement Sentiment

100

Strongly positive

Hospira acquired Orchid's generic injectables business in India for ~$400M, including manufacturing and pipeline.

Did it work? Outcome assessment

Strategic verdict

Partially Achieved

Financial impact

Dilutive

Pipeline outcome

Mixed

Assessment window: 5yr post-close.